TNFSF10 and neoplasm: Tumor necnosis factor-related apoptosis-inducing ligand (TRAIL) and doxorubicin (DOX) as the most important extracellular activators of apoptosis, were simultaneously incorporated into PM-NV (TRAIL-DOX-PM-NV) for tumor therapy.